Synthesis of piperazine-based thiazolidinones as VEGFR2 tyrosine kinase inhibitors inducing apoptosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthesis of piperazine-based thiazolidinones as VEGFR2 tyrosine kinase inhibitors inducing apoptosis
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 9, Issue 15, Pages 1709-1729
Publisher
Future Science, LTD
Online
2017-09-19
DOI
10.4155/fmc-2017-0072
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis and biological evaluation of novel isoxazolines linked via piperazine to 2- benzoisothiazoles as potent apoptotic agents
- (2017) Sathish Byrappa et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents
- (2017) Wagdy M. Eldehna et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Staurosporine suppresses survival of HepG2 cancer cells through Omi/HtrA2-mediated inhibition of PI3K/Akt signaling pathway
- (2017) Youming Ding et al. TUMOR BIOLOGY
- 5-Ene-4-thiazolidinones induce apoptosis in mammalian leukemia cells
- (2016) Julia Senkiv et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of new benzimidazole-thiazolidinedione hybrids as potential cytotoxic and apoptosis inducing agents
- (2016) Pankaj Sharma et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Staurosporine scaffold-based rational discovery of the wild-type sparing reversible inhibitors of EGFR T790M gatekeeper mutant in lung cancer with analog-sensitive kinase technology
- (2016) Xiaoyun Song et al. JOURNAL OF MOLECULAR RECOGNITION
- Discovery of New 4-Alkoxyquinazoline-Based Derivatives as Potent VEGFR2 Inhibitors
- (2015) Yong Yin et al. Chemical Biology & Drug Design
- Synthesis and biological evaluation of novel aromatic-heterocyclic biphenyls as potent anti-leukemia agents
- (2015) Jinyun Dong et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of N -[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2- b ]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1 H -pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitor
- (2013) Naoki Miyamoto et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Design, synthesis, quantum chemical studies and biological activity evaluation of pyrazole–benzimidazole derivatives as potent Aurora A/B kinase inhibitors
- (2013) Youguang Zheng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Ins and Outs of Kinase DFG Motifs
- (2013) Daniel K. Treiber et al. CHEMISTRY & BIOLOGY
- Emerging Paradigms in the Development of Resistance to Tyrosine Kinase Inhibitors in Lung Cancer
- (2013) Justin F. Gainor et al. JOURNAL OF CLINICAL ONCOLOGY
- KLIFS: A Knowledge-Based Structural Database To Navigate Kinase–Ligand Interaction Space
- (2013) Oscar P. J. van Linden et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, biological evaluation, and molecular docking studies of N-((1,3-diphenyl-1H-pyrazol-4-yl)methyl)aniline derivatives as novel anticancer agents
- (2012) Xian-Feng Huang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The design, synthesis, and biological evaluation of potent receptor tyrosine kinase inhibitors
- (2012) Moon H. Kim et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis, biological evaluation, and molecular docking studies of N,1,3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents
- (2012) Xi Li et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis of New 4-Thiazolidinone-, Pyrazoline-, and Isatin-Based Conjugates with Promising Antitumor Activity
- (2012) Dmytro Havrylyuk et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors
- (2012) M. McTigue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anticancer molecules targeting fibroblast growth factor receptors
- (2012) Guang Liang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Protein kinase biochemistry and drug discovery
- (2011) Phillip A. Schwartz et al. BIOORGANIC CHEMISTRY
- Design, synthesis and biological evaluation of novel 4-thiazolidinones containing indolin-2-one moiety as potential antitumor agent
- (2011) Shuobing Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of pyrazole derivatives as potential multi-kinase inhibitors in hepatocellular carcinoma
- (2011) Elena Strocchi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway
- (2011) Andree Yeramian et al. INTERNATIONAL JOURNAL OF CANCER
- Tri- and Tetrasubstituted Pyrazole Derivates: Regioisomerism Switches Activity from p38MAP Kinase to Important Cancer Kinases
- (2011) Bassam Abu Thaher et al. JOURNAL OF MEDICINAL CHEMISTRY
- Molecularly targeted therapy in hepatocellular carcinoma
- (2010) Hung Huynh BIOCHEMICAL PHARMACOLOGY
- Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region
- (2010) Yu Mi Ahn et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Synthesis and In Vitro Evaluation of Some Isatin-Thiazolidinone Hybrid Analogues as Anti-Proliferative Agents
- (2010) P. K. Ramshid et al. Medicinal Chemistry
- On the Origins of Enzyme Inhibitor Selectivity and Promiscuity: A Case Study of Protein Kinase Binding to Staurosporine
- (2009) Duangrudee Tanramluk et al. Chemical Biology & Drug Design
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
- (2009) Garrett M. Morris et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation
- (2009) Fabio Zuccotto et al. JOURNAL OF MEDICINAL CHEMISTRY
- 5-Substituted pyrido[2,3-d]pyrimidine, an inhibitor against three receptor tyrosine kinases
- (2008) Naparat Kammasud et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Type-II Kinase Inhibitor Docking, Screening, and Profiling Using Modified Structures of Active Kinase States
- (2008) Irina Kufareva et al. JOURNAL OF MEDICINAL CHEMISTRY
- Naphthamides as Novel and Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Design, Synthesis, and Evaluation¶
- (2008) Jean-Christophe Harmange et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacophore modeling studies of type I and type II kinase inhibitors of Tie2
- (2008) Qing-Qing Xie et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now